二尖瓣轮形成术设备的开发平台 - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2024年版)

二尖瓣轮形成术设备，与二尖瓣的修復所使用的环状成形术术环用带被构成。

本报告提供二尖瓣轮形成术设备市场相关调查，提供产品概要与正在开发的开发中产品趋势，各种处于开发阶段产品的比较分析和进行中的临床试验相关资讯，及参与企业的最近的趋势等资讯。

目录

第1章 目录

第2章 简介

第3章 开发中的产品

• 二尖瓣轮形成术设备 - 各开发阶段平台产品
• 二尖瓣轮形成术设备 - 各地区开发中产品
• 二尖瓣轮形成术设备 - 各法规途径开发中产品
• 二尖瓣轮形成术设备 - 估计核准日开发中产品
• 二尖瓣轮形成术设备 - 进行中的临床试验

第4章 二尖瓣轮形成术设备- 各公司正在开发的开发中产品

• 二尖瓣轮形成术设备企业- 各开发阶段的开发中产品
• 二尖瓣轮形成术设备- 各开发阶段的开发中产品

第5章 二尖瓣轮形成术设备的企业与产品概要

• Affluent Medical SASU
• Anchorvalve
• Boston Scientific Corp
• CUBE SRL
• HVR Cardio Oy
• MiCardia Corp
• Michigan Critical Care Consultants Inc
• Millipede LLC
• Mitre Medical Corp
• Rambam Health Care Campus
• Syntach AB
• Tau Pnu Medical Co., Ltd.
• TransCardiac Therapeutics, LLC
• Transmural systems LLC
• TTK Healthcare Ltd
• Valcare Medical
• Valtech Cardio Ltd

第6章 二尖瓣轮形成术设备-最近的趋势

第7章 附录

GlobalData's Medical Devices sector report, "Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Mitral Valve Annuloplasty Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Mitral Valve Annuloplasty Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Mitral Valve Annuloplasty Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Mitral Valve Annuloplasty Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Mitral Valve Annuloplasty Devices Overview

3 Products under Development

• 3.1 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development
• 3.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Territory
• 3.3 Mitral Valve Annuloplasty Devices - Pipeline Products by Regulatory Path
• 3.4 Mitral Valve Annuloplasty Devices - Pipeline Products by Estimated Approval Date
• 3.5 Mitral Valve Annuloplasty Devices - Ongoing Clinical Trials

4 Mitral Valve Annuloplasty Devices - Pipeline Products under Development by Companies

• 4.1 Mitral Valve Annuloplasty Devices Companies - Pipeline Products by Stage of Development
• 4.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development

5 Mitral Valve Annuloplasty Devices Companies and Product Overview

• 5.1 Affluent Medical SASU Company Overview
  • 5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Anchorvalve Company Overview
  • 5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Boston Scientific Corp Company Overview
  • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 CUBE SRL Company Overview
  • 5.4.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 HVR Cardio Oy Company Overview
  • 5.5.1 HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 MiCardia Corp Company Overview
  • 5.6.1 MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Michigan Critical Care Consultants Inc Company Overview
  • 5.7.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Millipede LLC Company Overview
  • 5.8.1 Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Mitre Medical Corp Company Overview
  • 5.9.1 Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Rambam Health Care Campus Company Overview
  • 5.10.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Syntach AB Company Overview
  • 5.11.1 Syntach AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Tau Pnu Medical Co., Ltd. Company Overview
  • 5.12.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 TransCardiac Therapeutics, LLC (Inactive) Company Overview
  • 5.13.1 TransCardiac Therapeutics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Transmural systems LLC Company Overview
  • 5.14.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 TTK Healthcare Ltd Company Overview
  • 5.15.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Valcare Medical Company Overview
  • 5.16.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Valtech Cardio Ltd Company Overview
  • 5.17.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Mitral Valve Annuloplasty Devices- Recent Developments

• 6.1 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
• 6.2 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
• 6.3 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
• 6.4 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
• 6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
• 6.6 Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF)
• 6.7 Apr 15, 2024: Edwards Lifesciences Appoints New China Head
• 6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
• 6.9 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
• 6.10 Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review
• 6.11 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
• 6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
• 6.13 Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
• 6.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
• 6.15 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
• 6.16 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer